SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,487,547 | -33.2% | 65,382 | -19.7% | 0.27% | +5.0% |
| Q1 2023 | $11,217,019 | +0.7% | 81,383 | -5.3% | 0.26% | +35.9% |
| Q4 2022 | $11,138,049 | +1.3% | 85,955 | -13.6% | 0.19% | +2.7% |
| Q3 2022 | $10,996,000 | +171.4% | 99,477 | +91.8% | 0.19% | +136.7% |
| Q1 2022 | $4,051,000 | -8.2% | 51,860 | +5.8% | 0.08% | -31.9% |
| Q4 2021 | $4,413,000 | +7.7% | 49,009 | +10.6% | 0.12% | +54.7% |
| Q3 2021 | $4,098,000 | +62.7% | 44,309 | +31.1% | 0.08% | +74.4% |
| Q1 2021 | $2,519,000 | – | 33,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |